Jazz Pharmaceuticals Letterhead]Transition and Separation Agreement • May 8th, 2018 • Jazz Pharmaceuticals PLC • Pharmaceutical preparations • California
This letter sets forth the terms of the transition and separation agreement (the “Agreement”) between you and Jazz Pharmaceuticals, Inc. (the “Company”).
AMENDMENT NO. 1 CLINICAL AND COMMERCIAL MANUFACTURING AND SUPPLY AGREEMENTClinical and Commercial Manufacturing and Supply Agreement • May 8th, 2018 • Jazz Pharmaceuticals PLC • Pharmaceutical preparations
This Amendment No. 1 (“Amendment No. 1”) is entered into by JAZZ PHARMACEUTICALS IRELAND LIMITED (“JAZZ”) and BAXTER ONCOLOGY GmbH (“Baxter”) as of January 18, 2018 (“Amend No. 1 Effective Date”).
